Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes of the NVT ALLEGRA TAVI System TF in Failing Calcified Aortic Heart Valves in a Real-world Patient Population With Elevated Surgical Risk

NCT03613246 is registered in ClinicalTrials.gov with NVT GmbH as lead sponsor.

NCT NCT03613246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03613246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes of the NVT ALLEGRA TAVI System TF in Failing Calcified Aortic Heart Valves in a Real-world Patient Population With Elevated Surgical Risk
Lead sponsor
NVT GmbH
Phase
Observational
Overall status
Active, not recruiting
Start date
February 20, 2019
Completion date
January 26, 2029
Enrollment
346 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

transcatheter aortic valve implantation